ATM safeguards liver homeostasis by mitigating mitochondrial hypermetabolism and bioenergetic crisis in MASLD.
The rising incidence of Metabolic dysfunction-associated steatotic liver disease (MASLD) and its progressive stage, Metabolic dysfunction-associated steatohepatitis (MASH), represents the most prevalent chronic liver condition and a major health problem. Key molecular mechanisms driving this progression remain unclear....